Backgrounds/Aims: To explore whether NLRP3 is involved in the development of cataract and to study the effect of NLRP3 on hydrogen peroxide (H2O2)-induced injury in human lens epithelial cells. Methods: Oxidative stress-induced apoptosis model was constructed by treating HLEB3 cells with 50 µM H2O2 at different times (6 h, 12 h) and was confirmed by flow cytometry and Western blot. HLEB3 were divided into NC, NC+H2O2, shNLRP3, and shNLRP3+H2O2 groups. Quantitative real-time polymerase chain reaction and Western blot were employed to detect mRNA and protein expressions, DCFH-DA to measure reactive oxygen species production, and Annexin V-FITC/PI staining to determine cell apoptosis. Results: NLRP3 expression significantly increased in H2O2-induced HLEB3 cells. shRNA interference of NLRP3 inflammasome protects HLEB3 cells against oxidative stress-induced apoptosis by decreasing the expression levels of caspase-3 and Bax and increasing Bcl-2 expression. shNLRP3 was able to effectively suppress H2O2-induced apoptosis via inhibition of NF-κB signaling. Conclusion: NLRP3 might be involved in the apoptosis of lens epithelial cells. The inhibition of NLRP3 obviously attenuated H2O2-induced oxidative stress injury of human lens epithelial cells via NF-κB signaling.

1.
Liu
YC
,
Wilkins
M
,
Kim
T
,
Malyugin
B
,
Mehta
JS
.
Cataracts
.
Lancet
.
2017
Aug
;
390
(
10094
):
600
12
.
[PubMed]
0140-6736
2.
Mok
JW
,
Chang
DJ
,
Joo
CK
.
Antiapoptotic effects of anthocyanin from the seed coat of black soybean against oxidative damage of human lens epithelial cell induced by H2O2
.
Curr Eye Res
.
2014
Nov
;
39
(
11
):
1090
8
.
[PubMed]
0271-3683
3.
Nita
M
,
Grzybowski
A
.
The Role of the Reactive Oxygen Species and Oxidative Stress in the Pathomechanism of the Age-Related Ocular Diseases and Other Pathologies of the Anterior and Posterior Eye Segments in Adults
.
Oxid Med Cell Longev
.
2016
;
2016
:
3164734
3164734
.
[PubMed]
1942-0900
4.
Feng
K
,
Guo
HK
.
Eaf2 protects human lens epithelial cells against oxidative stress‑induced apoptosis by Wnt signaling
.
Mol Med Rep
.
2018
Feb
;
17
(
2
):
2795
802
.
[PubMed]
1791-3004
5.
Liochev
SI
.
Reactive oxygen species and the free radical theory of aging
.
Free Radic Biol Med
.
2013
Jul
;
60
:
1
4
.
[PubMed]
0891-5849
6.
Selin
JZ
,
Lindblad
BE
,
Rautiainen
S
,
Michaëlsson
K
,
Morgenstern
R
,
Bottai
M
, et al
Are increased levels of systemic oxidative stress and inflammation associated with age-related cataract?
Antioxid Redox Signal
.
2014
Aug
;
21
(
5
):
700
4
.
[PubMed]
1523-0864
7.
Tschopp
J
,
Schroder
K
.
NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?
Nat Rev Immunol
.
2010
Mar
;
10
(
3
):
210
5
.
[PubMed]
1474-1733
8.
He
Y
,
Hara
H
,
Núñez
G
.
Mechanism and Regulation of NLRP3 Inflammasome Activation
.
Trends Biochem Sci
.
2016
Dec
;
41
(
12
):
1012
21
.
[PubMed]
0968-0004
9.
Menu
P
,
Vince
JE
.
The NLRP3 inflammasome in health and disease: the good, the bad and the ugly
.
Clin Exp Immunol
.
2011
Oct
;
166
(
1
):
1
15
.
[PubMed]
0009-9104
10.
Marneros
AG
.
Increased VEGF-A promotes multiple distinct aging diseases of the eye through shared pathomechanisms
.
EMBO Mol Med
.
2016
Mar
;
8
(
3
):
208
31
.
[PubMed]
1757-4676
11.
Franchi
L
,
Eigenbrod
T
,
Muñoz-Planillo
R
,
Nuñez
G
.
The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis
.
Nat Immunol
.
2009
Mar
;
10
(
3
):
241
7
.
[PubMed]
1529-2908
12.
Jin
XH
,
Ohgami
K
,
Shiratori
K
,
Koyama
Y
,
Yoshida
K
,
Kase
S
, et al
Inhibition of nuclear factor-kappa B activation attenuates hydrogen peroxide-induced cytotoxicity in human lens epithelial cells
.
Br J Ophthalmol
.
2007
Mar
;
91
(
3
):
369
71
.
[PubMed]
0007-1161
13.
Williams
D
.
Oxidative Stress and the Eye
.
Volume 38
.
2008
.
14.
Wang
S
,
Guo
C
,
Yu
M
,
Ning
X
,
Yan
B
,
Zhao
J
, et al
Identification of H2O2 induced oxidative stress associated microRNAs in HLE-B3 cells and their clinical relevance to the progression of age-related nuclear cataract
.
BMC Ophthalmol
.
2018
Apr
;
18
(
1
):
93
.
[PubMed]
1471-2415
15.
Peng
J
,
Zheng
TT
,
Liang
Y
,
Duan
LF
,
Zhang
YD
,
Wang
LJ
, et al
p-Coumaric Acid Protects Human Lens Epithelial Cells against Oxidative Stress-Induced Apoptosis by MAPK Signaling
.
Oxid Med Cell Longev
.
2018
Apr
;
2018
:
8549052
.
[PubMed]
1942-0900
16.
Bai
J
,
Zheng
Y
,
Dong
L
,
Cai
X
,
Wang
G
,
Liu
P
.
Inhibition of p38 mitogen-activated protein kinase phosphorylation decreases H₂O₂-induced apoptosis in human lens epithelial cells
.
Graefes Arch Clin Exp Ophthalmol
.
2015
Nov
;
253
(
11
):
1933
40
.
[PubMed]
0721-832X
17.
Im
H
, J Ammit A: The NLRP3 inflammasome: Role in airway inflammation, vol. 44;
2013
.
18.
Zheng
Q
,
Ren
Y
,
Reinach
PS
,
She
Y
,
Xiao
B
,
Hua
S
, et al
Reactive oxygen species activated NLRP3 inflammasomes prime environment-induced murine dry eye
.
Exp Eye Res
.
2014
Aug
;
125
:
1
8
.
[PubMed]
0014-4835
19.
Sun
SC
.
The non-canonical NF-κB pathway in immunity and inflammation
.
Nat Rev Immunol
.
2017
Sep
;
17
(
9
):
545
58
.
[PubMed]
1474-1733
20.
Dudek
EJ
,
Shang
F
,
Taylor
A
.
H(2)O(2)-mediated oxidative stress activates NF-kappa B in lens epithelial cells
.
Free Radic Biol Med
.
2001
Sep
;
31
(
5
):
651
8
.
[PubMed]
0891-5849
21.
Shao
DW
,
Zhu
XQ
,
Huo
L
,
Sun
W
,
Pan
P
,
Chen
W
, et al
The significance of Akt/NF-κb signaling pathway in the posterior cataract animal model
.
Bratisl Lek Listy
.
2017
;
118
(
7
):
423
6
.
[PubMed]
0006-9248
22.
Yi
H
,
Peng
R
,
Zhang
LY
,
Sun
Y
,
Peng
HM
,
Liu
HD
, et al
LincRNA-Gm4419 knockdown ameliorates NF-κB/NLRP3 inflammasome-mediated inflammation in diabetic nephropathy
.
Cell Death Dis
.
2017
Feb
;
8
(
2
):
e2583
2583
.
[PubMed]
2041-4889
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.